Bala Cynwyd, Pennsylvania--(Newsfile Corp. - May 23, 2023) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of CohBar, Inc. ("CohBar" or the "Company") (NASDAQ: CWBR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to merge with Morphogenesis, Inc. ("Morphogenesis"). Under the terms of the merger agreement, each holder of CohBar common stock as of immediately prior to the closing of the transaction will be issued a dividend equal to approximately 3.30 shares of CohBar common stock. On a pro forma basis, pre-merger CohBar equityholders are expected to collectively own approximately 15% and pre-merger Morphogenesis equityholders are expected to collectively own approximately 77%, respectively, of the common stock of CohBar on a pro forma basis
The investigation concerns whether the CohBar Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Company shareholders in the combined company.
If you own shares of CohBar stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/cohbar-inc-nasdaq-cwbr/, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/167132
